Anurag Singh is a Scientific Director at Pfizer Oncology, specializing in Antibody-Drug Conjugate (ADC) Biology and leading early discovery research programs with a focus on next-generation payloads. They have extensive experience in cancer cell biology, targeted therapeutics, and precision medicine, having previously led a multi-disciplinary team at Pfizer-Boulder in targeted drug development. Anurag also served as an Assistant Professor at Boston University School of Medicine, where they mentored students and oversaw the Biomolecular Pharmacology PhD training program. Their earlier roles included Postdoctoral Fellow and Instructor at Massachusetts General Hospital, and a Senior Principal Scientist in Translational Research at Pfizer. Anurag obtained their education from Stony Brook University from 2000 to 2005.
This person is not in the org chart
This person is not in any teams
This person is not in any offices